Back
Day Range
$10.88
$10.88
52-Week Range
$3.28
$10.88
Volume
500
50D / 200D Avg
$8.14
/
$4.95
Prev Close
$10.88
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 361.3 | 0.4 |
| P/B | 7.9 | 2.9 |
| ROE % | 2.2 | 3.7 |
| Net Margin % | 2.3 | 3.9 |
| Rev Growth 5Y % | 205.9 | 10.0 |
| D/E | 0.9 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
-$0.34
-$0.52 – -$0.18
|
63 M | 1 |
| FY2028 |
$0.17
$0.09 – $0.27
|
84 M | 1 |
| FY2027 |
$0.60
$0.33 – $0.93
|
99 M | 1 |
Key Takeaways
Revenue grew 205.92% annually over 5 years — strong growth
ROE of 2.20% is below average
Generating 14.22M in free cash flow
P/E of 361.25 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 71.36%
Cash machine — converts 943.66% of earnings into free cash flow
Growth
Revenue Growth (5Y)
205.92%
Revenue (1Y)134.56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
2.20%
ROIC1.87%
Net Margin2.25%
Op. Margin4.90%
Safety
Debt / Equity
0.90
Current Ratio1.23
Interest Coverage0.69
Valuation
P/E Ratio
361.25
P/B Ratio7.86
EV/EBITDA159.93
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 134.56% | Revenue Growth (3Y) | 82.15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 205.92% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 67.00M | Net Income (TTM) | 1.51M |
| ROE | 2.20% | ROA | 1.00% |
| Gross Margin | 99.55% | Operating Margin | 4.90% |
| Net Margin | 2.25% | Free Cash Flow (TTM) | 14.22M |
| ROIC | 1.87% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.90 | Current Ratio | 1.23 |
| Interest Coverage | 0.69 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 361.25 | P/B Ratio | 7.86 |
| P/S Ratio | 8.13 | PEG Ratio | -1.08 |
| EV/EBITDA | 159.93 | Dividend Yield | 0.00% |
| Market Cap | 544.40M | Enterprise Value | 524.75M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 67.00M | 28.57M | 20.20M | 80.07M | 765,000.0 |
| Net Income | 1.51M | -28.89M | -23.72M | 67.26M | -101.22M |
| EPS (Diluted) | 0.03 | -0.58 | -0.48 | 1.23 | -2.60 |
| Gross Profit | 66.70M | 28.22M | 19.95M | 79.91M | 563,000.0 |
| Operating Income | 3.28M | -26.58M | -27.29M | 31.82M | -82.90M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 151.42M | 173.87M | 215.54M | 281.72M | 198.61M |
| Total Liabilities | 82.20M | 105.92M | 121.01M | 162.62M | 214.78M |
| Shareholders' Equity | 69.22M | 67.95M | 94.53M | 119.10M | -16.16M |
| Total Debt | 62.13M | 70.18M | 75.28M | 74.24M | 185.69M |
| Cash & Equivalents | 81.79M | 77.79M | 136.00M | 258.76M | 171.03M |
| Current Assets | 92.77M | 113.12M | 158.46M | 268.10M | 184.72M |
| Current Liabilities | 75.16M | 38.48M | 39.37M | 62.84M | 31.07M |